These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21088574)

  • 21. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up.
    Navarro-Díaz M; Serra A; Romero R; Bonet J; Bayés B; Homs M; Pérez N; Bonal J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S213-7. PubMed ID: 17130264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity-related glomerulopathy in China: a case series of 90 patients.
    Chen HM; Li SJ; Chen HP; Wang QW; Li LS; Liu ZH
    Am J Kidney Dis; 2008 Jul; 52(1):58-65. PubMed ID: 18423814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
    Chalmers L; Kaskel FJ; Bamgbola O
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathophysiology of minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
    Cho MH; Hong EH; Lee TH; Ko CW
    Nephrology (Carlton); 2007 Dec; 12 Suppl 3():S11-4. PubMed ID: 17995521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low glomerular density with glomerulomegaly in obesity-related glomerulopathy.
    Tsuboi N; Utsunomiya Y; Kanzaki G; Koike K; Ikegami M; Kawamura T; Hosoya T
    Clin J Am Soc Nephrol; 2012 May; 7(5):735-41. PubMed ID: 22403274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sickle cell glomerulopathy with focal segmental glomerulosclerosis.
    Verani RR; Conley SB
    Child Nephrol Urol; 1991; 11(4):206-8. PubMed ID: 1777902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Permeability factors in focal segmental glomerulosclerosis.
    Savin VJ; McCarthy ET; Sharma M
    Semin Nephrol; 2003 Mar; 23(2):147-60. PubMed ID: 12704575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tip variant of focal segmental glomerulosclerosis: outcome and comparison to 'not otherwise specified' variant.
    Arias LF; Franco-Alzate C; Rojas SL
    Nephrol Dial Transplant; 2011 Jul; 26(7):2215-21. PubMed ID: 21068139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Idiopathic focal segmental glomerulosclerosis.
    Schnaper HW
    Semin Nephrol; 2003 Mar; 23(2):183-93. PubMed ID: 12704578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Podocyte lesions in patients with obesity-related glomerulopathy.
    Chen HM; Liu ZH; Zeng CH; Li SJ; Wang QW; Li LS
    Am J Kidney Dis; 2006 Nov; 48(5):772-9. PubMed ID: 17059996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary focal segmental glomerulosclerosis--long-term outcome after pediatric renal transplantation.
    Jungraithmayr TC; Bulla M; Dippell J; Greiner C; Griebel M; Leichter HE; Plank C; Tönshoff B; Weber LT; Zimmerhackl LB;
    Pediatr Transplant; 2005 Apr; 9(2):226-31. PubMed ID: 15787798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obesity, insulin resistance and kidney disease risk: insights into the relationship.
    Sarafidis PA
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):450-6. PubMed ID: 18695384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kidney disease in the obese patient.
    Naguib MT
    South Med J; 2014 Aug; 107(8):481-5. PubMed ID: 25084184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic syndrome and chronic kidney disease: a Japanese perspective on a worldwide problem.
    Iseki K
    J Nephrol; 2008; 21(3):305-12. PubMed ID: 18587718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obesity and target organ damage: the kidney.
    de Jong PE; Verhave JC; Pinto-Sietsma SJ; Hillege HL;
    Int J Obes Relat Metab Disord; 2002 Dec; 26 Suppl 4():S21-4. PubMed ID: 12457295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal manifestations in the metabolic syndrome.
    Locatelli F; Pozzoni P; Del Vecchio L
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S81-5. PubMed ID: 16565254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin antagonists and steroids in the treatment of focal segmental glomerulosclerosis.
    Korbet SM
    Semin Nephrol; 2003 Mar; 23(2):219-28. PubMed ID: 12704582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Two cases of idiopathic membranous nephropathy with focal and segmental glomerulosclerotic lesions in which renal function progressively deteriorated].
    Suzuki R; Morita H; Mizobuchi M; Nemoto T; Sato Y; Niikura K; Ideura T; Yoshimura A
    Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):381-7. PubMed ID: 10998919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Obesity: what impact on renal function?].
    Mathieu C; Teta D; Vogt B; Burnier M
    Rev Med Suisse; 2006 Mar; 2(55):576-8, 580-1. PubMed ID: 16562600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Metabolic syndrome related kidney injury].
    Chen YP
    Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(30):2093-4. PubMed ID: 17064609
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.